Rights and permissions
About this article
Cite this article
Cisplatin plus either paclitaxel or cyclophosphamide benefits QOL. Pharmacoecon. Outcomes News 467, 10 (2004). https://doi.org/10.2165/00151234-200404670-00025
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200404670-00025